Crescent Biopharma, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Crescent Biopharma, Inc. (CBIO) is 309.37M

According to Crescent Biopharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 309.37M. This represents a change of 46.79% compared to the average of 210.76M of the last 4 quarters.

Crescent Biopharma, Inc. (CBIO) Historical Enterprise Value (quarterly & annually)

How has CBIO Enterprise Value performed in the past?

The mean historical Enterprise Value of Crescent Biopharma, Inc. over the last ten years is 89.02M. The current 309.37M Enterprise Value has changed 247.52% with respect to the historical average. Over the past ten years (40 quarters), CBIO's Enterprise Value was at its highest in in the June 2018 quarter at 461.09M. The Enterprise Value was at its lowest in in the June 2025 quarter at -88750230.50.

Crescent Biopharma, Inc. (CBIO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Crescent Biopharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Crescent Biopharma, Inc. (CBIO) Average Enterprise Value

How has CBIO Enterprise Value performed in the past?

The current Enterprise Value of Crescent Biopharma, Inc. (CBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Crescent Biopharma, Inc. (CBIO) Enterprise Value vs. Peers

How is CBIO’s Enterprise Value compared to its peers?

Crescent Biopharma, Inc.’s Enterprise Value is greater than MacroGenics, Inc. (78.52M), greater than NovaBridge Biosciences (-61115332.00), less than CytomX Therapeutics, Inc. (466.77M), greater than Context Therapeutics Inc. (-24691121.00), greater than Compugen Ltd. (177.93M), less than Veraxa Biotech Holding AG (0), greater than Compass Therapeutics, Inc. (110.67M), less than Celldex Therapeutics, Inc. (2.21B), less than Arcus Biosciences, Inc. (2.21B), less than Zymeworks Inc. (2.13B),

Build a custom stock screener for Crescent Biopharma, Inc. (CBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Crescent Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Crescent Biopharma, Inc. (CBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Crescent Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.